Inventory Optimization - Medical Device Supply Chain Council
Transcription
Inventory Optimization - Medical Device Supply Chain Council
Inventory Optimization May 23, 2006 Todd Jackson, VP of Supply Chain Planning at Boston Scientific Sean Willems, Chief Scientist at Optiant Agenda BSC Overview – Key Stats – Products – History Operations Excellence at BSC – Early challenges – Resolution of challenges Multi-Echelon Inventory Optimization at BSC – Supply chain structure – Advances Boston Scientific Corporation Confidential 2 Boston Scientific is a global, multi-billion dollar company focused on less-invasive medical devices and procedures Boston Scientific Corporation Profile General Facts: Product Innovation: • Founded in 1979 with 38 employees, $2 million in sales. Now Fortune 500 company • 9,790 Patents issued worldwide • $680 Million invested in R&D (’05) • $540 Million in 40 Investments (’05) • World’s largest medical device company dedicated to less-invasive therapies • Portfolio of 15,000 products, many with market leading positions ® • The TAXUS drug eluting stent has been the most successfully launched product in the history of the industry • Corporate HQ: Natick, MA • Regional HQs: Singapore, Paris, Tokyo • Website: www.bostonscientific.com Financials: • • • • $6.3 Billion Revenue (’05) 29% CAGR* (’02-’05) $1.5 Billion Net Income (’05) NYSE: BSX Demographics: • 20,000 Employees • Direct marketing & sales in more than 40 countries • 16 Primary manufacturing locations in U.S., Ireland & Costa Rica * Compound Annual Growth Rate Boston Scientific Corporation Confidential 3 Over 25 years of Innovation has led to a broad portfolio of more than 15,000 products Sampling of Boston Scientific’s Product Portfolio Detachable Coils Balloons Grafts Enteral Feeding Ablation Cardiac Mapping Embolics Stents Stone Retrieval Embolic Protection Biopsy Systems Peripheral Dilatation Ureteral Stents Catheters / Guidewires Neuro-stimulation Boston Scientific Corporation Confidential 4 Boston Scientific has evolved from early pioneer to industry leader Global Leadership in Interventional Medicine TAXUS Express U.S. FDA approval Revenue ($Millions) $6,283 6283 5,624 First clinical trial of drugeluting stent BSC acquires eight companies in two years 3,476 2,919 2,842 2,664 1,831 John Abele and Pete Nicholas partner to form Boston Scientific 3 8 13 16 '79 '80 '81 '82 '83 2,673 2,234 BSC goes public with IPO on NYSE 2 Phase IV Next Chapter 1,551 1,191 31 47 71 116 159 22 99 230 '84 '85 '86 '87 '88 '89 '90 '91 315 380 449 '92 '93 '94 Phase I Less-Invasive Medicine Pioneer/Leader '95 '96 '97 '98 '99 Phase II Strategic Mass (Via Acquisitions) Boston Scientific Corporation Confidential '00 '01 '02 '03 '04 '05 Phase III Stent Integration & Drug-Eluting Stent Leadership 5 BSC’s Operations Excellence Approach Boston Scientific Corporation Confidential 6 BSC boasts one of industry’s best performing supply chains given the formidable challenges BSC Supply Chain Performance Key Challenges • Highly regulated operations environment • High supply chain complexity – – – – – High level of vertical integration High number of supply nodes Direct distribution to the customers Large number of BSC owned distribution centers Large number of suppliers • High Level of organic growth – Entry into new markets – Emphasis on growth in new geographies – 15,000 products Next day delivery on most orders Consistent 98% service levels Industry leading inventory turns Globally expanding scope (40+ countries) Advanced planning capabilities and supply chain visibility • Exceptional forecast accuracy for both mature and new products • Relatively short manufacturing and • Growth through acquisitions – Supply chain integration for the new companies – Scalability of BSC processes and systems • Continuously evolving product portfolios – 40% revenue from new products – Constantly rationalizing product lines • • • • • distribution lead times • BSC has been recognized through industry benchmarking and national awards in the areas of manufacturing, logistics, customer service, and inventory performance – Lean Manufacturing facilities • 2005 Shingo Prize at Maple Grove (MN) • 2006 Industry Week “Best 10” at Wayne (NJ) – Boston Scientific’s Quincy Call Center • 3x North Face Award for Customer Service • 2005 J.D. Power: Customer Service excellence” – Inventory performance benchmarked in top quartile of Medical Device Industry Boston Scientific Corporation Confidential 7 However it wasn’t always like this… we experienced all the challenges reminiscent of a poorly performing supply chain • Constant firefighting mode • Frequent stock-outs • Frequent expedites involving premium freight • • • • Excessive inventory Poor inventory mix Pre-1999 Poor forecast accuracy Long manufacturing and transportation lead times • Frequent write-offs of excess and obsolete inventory • Suboptimal logistics network • Poor risk mitigation Stage 1: Functional Focus Discrete supply chain processes and data flows well documented and understood Performance measured at functional level Stage 2: Internal Integration Company-wide process and data model continuously measured at the company, process, and diagnostic levels Stage 3: External Integration Strategic partners throughout the global supply chain collaborate to: • Identify joint business objectives and action plans • Enforce common processes and data sharing • Define, monitor, and react to performance metrics Stage 4: Cross-Enterprise Collaboration IT and eBusiness solutions enable a collaborative supply chain strategy that: • Aligns participating companies’ business objectives and associated processes • Results in real-time planning, decisionmaking, and execution of supply chain responses to customer requirements Supply Chain Maturity Boston Scientific Corporation Confidential 8 We undertook a Supply Chain Transformation in the late 90’s, that was grounded in four basic guiding principles 3) Improved supply chain responsiveness by compressing the order fulfillment lead times by driving lean thinking from manufacturing through distribution 1) Hybrid replenishment process that uses forecasts to make capacity plans and raw material purchases, but consumption data to drive production schedule mix Forecasts used to plan capacity 7 50 10 0% 25.0 MRP 1 0 0 .0 % 7 00 DRP 90 % 9 0 .0 % 6 50 80 % 6 00 20.0 8 0 .0 % 5 50 70 % 7 0 .0 % 60 % 4 00 50 % 3 50 3 00 Tier Tier22 40 % 15.0 6 0 .0 % 5 0 .0 % 10.0 Service Level 4 50 Inventory Turns Daily orders based on recent consumption Units of Demand Weekly orders based on global consumption and safety stock changes Percentage Accuracy 5 00 Weekly orders based on forecast 4 0 .0 % 2 50 30 % 3 0 .0 % 2 00 Tier Tier22 1 50 Customer Customer 20 % 5.0 2 0 .0 % 1 00 10 % 1 0 .0 % Pr e v io u s F o r ec a s t: A c tu a l S h ip me nts : F or e c as t A c c u r a c y T ar g e t Forecast vs Actual 2) Globally-pooled safety stocks that are analytically determined based on demand/supply volatility and lead time S e r v ic e L e v e l: Oct- 01 Dec-01 Nov-01 Jul-01 T a r g e t S e r v ic e L e v e l Sep-01 Jun-01 Aug-01 Apr-01 May-01 Jan-01 Mar-01 Feb-01 Oct-00 In v e n to r y T u r n s ( B a c kw a r d ) : Dec- 00 0.0 Nov-00 Oct-01 Dec-01 Nov-01 Jul-01 F o r ec a s t A c c ur a c y Sep-01 Jun-01 Aug-01 Apr-01 Cu r r e nt F or e c a s t: May-01 Jan-01 Mar-01 Feb-01 Oct-00 Dec-00 Nov-00 Jul-00 Sep-00 Aug- 00 0% Jun-00 0 Jul-00 50 Tier Tier22 Sep-00 Tier Tier11DC DC Aug-00 (1-3 (1-3days) days) Product Jun-00 Supplier Supplier Plant Plant 0 .0 % T a r g e t Tu r n s Turns,Service 4) Consolidated spend and procurement practices that leverage global demand and volume to drive efficiency Fact-Based Communication and Decision-Making Boston Scientific Corporation Confidential Systems and Tools 9 Supply Chain Network Configuration Suppliers Plants ~50 large strategic suppliers servicing multiple plants 1,000+ small suppliers ~50 OEM vendors supplying FG products 16 BSC facilities in the USA and Ireland 2 Off-shore Contract manufacturers Distribution Centers 1 Global CDC- USA 1 Int’l CDC -NL 17 Tier 2 regional DCs 6 Tier 3 local DCs Boston Scientific Corporation Confidential Customers Prime channel: Direct hospital deliveries Few Distributors in select Emerging Markets 10 Technical Environment: BSC BSC Hybrid Hybrid Replenishment Replenishment Model Model Tightly Tightly Couples Couples Sales Sales and and Production Production Forecasts used to plan capacity MRP Weekly orders based on forecast DRP Weekly orders based on global consumption and safety stock changes Daily orders based on recent consumption Tier Tier22 Supplier Supplier Plant Plant Product Tier Tier11DC DC (1-3 (1-3days) days) Tier Tier22 Customer Customer Tier Tier22 Guiding Principles • Hold minimum stock in Tier 2 DC to buffer “local” demand uncertainty over Tier 1 lead times • Use analytical safety stock model • Buffer supply and demand variability Boston Scientific Corporation Confidential 11 Technical Environment: BSC BSC Hybrid Hybrid Replenishment Replenishment Model Model Tightly Tightly Couples Couples Sales Sales and and Production Production Forecasts used to plan capacity MRP Weekly orders based on forecast DRP Weekly orders based on global consumption and safety stock changes Daily orders based on recent consumption Tier Tier22 Supplier Supplier Plant Plant Product Tier Tier11DC DC (1-3 (1-3days) days) Tier Tier22 Customer Customer Tier Tier22 Guiding Principles • Ship daily to major Tier 2 DC’s based on previous day’s sales • Pool global safety stock in Tier 1 DC’s • Set order frequency based on EOQ (daily for largest volume orders) Boston Scientific Corporation Confidential 12 Technical Environment: BSC BSC Hybrid Hybrid Replenishment Replenishment Model Model Tightly Tightly Couples Couples Sales Sales and and Production Production Forecasts used to plan capacity MRP Weekly orders based on forecast DRP Weekly orders based on global consumption and safety stock changes Daily orders based on recent consumption Tier Tier22 Supplier Supplier Plant Plant Product Tier Tier11DC DC (1-3 (1-3days) days) Tier Tier22 Customer Customer Tier Tier22 Guiding Principles • Plan capacity and raw materials purchases from forecast • Produce prior week’s/day’s sales up to reorder point • Produce complete mix weekly for most items • Schedule production mix using actual sales rather than forecast Boston Scientific Corporation Confidential 13 Supply Chain Performance through 2003 Consistent, Global Metrics Service Level Inventory Turns 100% 98% 96% 94% 92% 90% 4.0 3.0 2.0 1.0 0.0 1997 1998 1999 2000 2001 2002 2003 1995 1996 1997 1998 1999 2000 2001 2002 2003 Forecast Accuracy Obsolescence 90% 80% Mature New 70% 60% 50% $M 150 100 50 0 2000 2001 2002 2003 1997 1998 1999 2000 2001 2002 2003 Annual Operating Savings of $250M+ since 2000 Boston Scientific Corporation Confidential 14 Advanced Inventory Optimization Inventory optimization solution integrated with SAP for monthly planning • • • • Monthly inventory target calculation for 40,000 SKU-locations High volume, low and intermittent demand items Manufacturing and sterilization capacity constraints Batch size constraints at each tier along with periodic review A Tactical finished goods planning: SKU-location specific inventory targets for finished items including local and global demand at each DC B Common, tactical inventory planning for raw materials at each production facility: Analytical raw materials solution with optimized inventory for Kanban, min/max, and base stack policies C Internal expertise for strategic supply chain design: Strategic modeling for initiatives including sourcing strategy, postponement, new product introduction A B C Push Raw Materials/Mfg Pull Assembly/Sterilization Distribution Boston Scientific Corporation Confidential 15 Inventory Inventory Optimization Optimization Solution Solution Highlights Highlights Inventory Mix - Tier 1 Europe DOS 60 50 40 Original Targets Precise SKU-location targets for high volume SKUs offers capital reduction opportunity Optimized Targets Precise SKU-location targets for low volume SKUs allows consistent high service performance 30 20 10 M ... M 40 ... M 80 ... M 20 ... M 20 ... M 20 ... 4 M 0 ... M 20 ... M 10 ... M 20 ... M 60 ... M 40 ... M 20 ... 2 M 0 ... M 60 ... M 90 ... M 60 ... M 20 ... M 40 ... 4 M 0 ... M 30 ... M 40 ... M 60 ... M 40 ... M 40 ... M 30 … 90 0 • Multi-echelon inventory optimization considering all complex conditions including demand uncertainty and supply variability • 98-99% service performance with inventory planning fully integrated with SAP • The right inventories at the right place with precise targets for every global SKU location • Solution transparency—clear understanding for the drivers of efficiency and resulting inventory policy, which is important for successful solution adoption Boston Scientific Corporation Confidential 16 Boston Scientific Building Lasting Change Provide a common worldwide ERP Platform • Process harmonization • Initial visibility to transactional data 1998 – Implemented SAP R/3 Establish Baseline Planning Processes • Introduced hybrid push/pull planning model • Custom safety stock calculator/database • Efficiency benefits ramped and began to plateau 1999 – Supply Chain Transformation Define and Understand the Efficient Frontier 2003 – Optiant Proof of Concept • 10-15% opportunity within distribution alone • Inventory optimization coupled with strategic planning • Demonstrated expertise and depth Monthly Inventory Targets to all Franchises Worldwide 2004 – Organizational Adoption • Proof of concept savings confirmed • Integrated data model and targets uploaded directly to SAP • Safety stock targets for 40,000 SKU-locations monthly Near-term Opportunities with Low Investment 2005 – Optimized FG Parameters • Daily vs. weekly planning • Actual supply uncertainty calculated monthly • Batch-size and periodic review considerations Common Raw Material Planning Platform 2006 – Optimized RM Parameters • Centralized planning for all SAP plants • Significant production improvement expected Target Franchise Opportunities 2006 – Strategic Modeling Institutionalized Boston Scientific Corporation Confidential • Building organizational competency • Leveraging APO source data 17 Guiding Principles The Benefits of 20/20 Hindsight • Structured pursuit of Artificial Volatility – Driven by the best of intentions, …with a splash of ignorance – Begins with cross-functional attitudes • Tactical foundation to enable Strategic modeling – Organizational learning environment – Aggressive continuous improvement,…bounded by intelligence • Ready Æ Aim Æ Fire • Managing the Inputs – Users learn to appreciate the force of their levers across multiple nodes – Reflective of a true management system that transcends individuals Boston Scientific Corporation Confidential 18 Multi-Echelon Inventory Optimization • • • • What is multi-echelon inventory optimization? How did we get here? What does it look like? Best practices – How do companies integrate inventory optimization into their business processes? – What organizational structure works best? – How do companies gain value? • Q&A Boston Scientific Corporation Confidential 19 Multi-echelon Inventory Motivation Three potential inventory policies for a simple serial supply chain Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 Boston Scientific Corporation Confidential 20 Multi-echelon Inventory Motivation Outsourcing production is an option Multiple classes of demand exist Product can be converted Boston Scientific Corporation Confidential 21 These Chains Can Get Complicated… Hundreds of SKUs Sharing tens of assemblies That each have their own common components Boston Scientific Corporation Confidential 22 Evolution of Inventory Optimization w/in the Enterprise Supplier Design to Build Forecast to Plan Order to Cash Customer Networked Optimized Supplier Customer Shipping Manufacturing Planning Purchasing Integrated Traditional Boston Scientific Corporation Confidential 23 Boston Scientific Supply Chain Challenges Manufacturing Manufacturing and and Sterilization Sterilization Capacity Capacity Constraints Constraints High High 98-99% 98-99% Service Service Performance Performance for for all all SKUs SKUs Large Large SKU SKU proliferation proliferation and and Consignment Consignment Mix Mix of of HighHigh- and and Low-volume, Low-volume, Intermittent Intermittent Demand Demand Individual Individual Raw Raw Material Material Planning Planning for for Each Each Plant Plant Batching Batching at at Each Each Tier Tier along along with with Periodic Periodic Review Review Heterogeneous Heterogeneous SKU/location SKU/location targets targets across across 66 global global business business units units Complex Complex 3-tier 3-tier Distribution Distribution Net Net Hybrid Hybrid Push-Pull Push-Pull System System with with Periodic Review Periodic Review between between Production Production & & Distribution Distribution Boston Scientific Corporation Confidential 24 Process to Improve Supply Chain Performance Configure supply chain and optimize inventory plan Optimize inventory targets over time 100% 90% 80% 60% 39 37 U U SK SK 31 35 U 29 33 U SK SK 25 27 U U SK SK 21 23 U U SK SK 17 19 U U SK SK 9 15 U U U U SK SK SK SK 7 5 11 U U SK SK 1 3 U U U U SK SK SK 13 50% Inventory 70% SK Strategic Inventory Optimization Time Tactical Inventory Optimization Close loop for next product generation Boston Scientific Corporation Confidential 25 Designing the Infrastructure for Inventory Optimization Boston Scientific Corporation Confidential 26 How to Deliver Value Across the Enterprise Boston Scientific Corporation Confidential 27 Q&A